Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study. by David Robinson, Hans Garmo, Pär Stattin, Karl Michaëlsson

Get full text

Prescription-based prediction of baseline mortality risk among older men. by Rolf Gedeborg, Hans Garmo, David Robinson, Pär Stattin

Get full text

The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries by Kerri Beckmann, Hans Garmo, Ingela Franck Lissbrant, Pär Stattin

Get full text

Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden by Yanina Balabanova, Bahman Farahmand, Pär Stattin, Hans Garmo, Gunnar Brobert

Get full text

Fathering of dizygotic twins and risk of prostate cancer: nationwide, population-based case-control study. by Sara Wirén, Linda Drevin, Olof Akre, David Robinson, Pär Stattin

Get full text

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based regi... by Marcus Westerberg, Sandra Irenaeus, Hans Garmo, Pär Stattin, Rolf Gedeborg

Get full text

Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic. by Rolf Gedeborg, Johan Styrke, Stacy Loeb, Hans Garmo, Pär Stattin

Get full text

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based regi... by Marcus Westerberg, Sandra Irenaeus, Hans Garmo, Pär Stattin, Rolf Gedeborg

Get full text

Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base... by David Thurtle, Ola Bratt, Pär Stattin, Paul Pharoah, Vincent Gnanapragasam

Get full text

How to measure temporal changes in care pathways for chronic diseases using health care registry data by Eugenio Ventimiglia, Mieke Van Hemelrijck, Lars Lindhagen, Pär Stattin, Hans Garmo

Get full text

Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study by Sylvia H. J. Jochems, Josef Fritz, Christel Häggström, Pär Stattin, Tanja Stocks

Get full text

1H HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples by Katarina Stenman, Pär Stattin, Hans Stenlund, Katrine Riklund, Gerhard Gröbner, Anders Bergh

Get full text

Observational study on time on treatment with abiraterone and enzalutamide. by Giuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, Francesco Montorsi, Hans Garmo, Pär Stattin

Get full text

A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0. by Beth Russell, Hans Garmo, Kerri Beckmann, Pär Stattin, Jan Adolfsson, Mieke Van Hemelrijck

Get full text

Androgen Deprivation Therapy and the Risk for Inguinal Hernia: An Observational Nested Case Control Study by Maria Hermann, Hanna Vikman, Pär Stattin, Asmatullah Katawazai, Ove Gustafsson, Johan Styrke, Gabriel Sandblom

Get full text

Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy by Andri Wilberg Orrason, Marcus Westerberg, Peter Albertsen, Johan Styrke, David Robinson, Hans Garmo, Pär Stattin

Get full text

Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression. by Peter Hammarsten, Mariateresa Cipriano, Andreas Josefsson, Pär Stattin, Lars Egevad, Torvald Granfors, Christopher J Fowler

Get full text

Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy. by Andri Wilberg Orrason, Marcus Westerberg, Peter Albertsen, Johan Styrke, David Robinson, Hans Garmo, Pär Stattin

Get full text

Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males by Mieke Van Hemelrijck, Eugenio Ventimiglia, David Robinson, Rolf Gedeborg, Lars Holmberg, Pär Stattin, Hans Garmo

Get full text

Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study by E. Lin, Hans Garmo, Mieke Van Hemelrijck, Jan Adolfsson, Pär Stattin, Björn Zethelius, Danielle Crawley

Get full text